-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
HIV-IN-6
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/301357-74-4.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 301357-74-4 |
| Description | HIV-IN-6 is a HIV-(cid:0) viral replication inhibitor by targeting Src family kinases (SFK) that interact with Nef protein of the virus, such as Hck. |
Product Information
| Synonyms | HIV-IN-6|301357-74-4|N-(3-((3-Hydroxyphenyl)amino)quinoxalin-2-yl)benzenesulfonamide|N-{3-[(3-Hydroxyphenyl)amino]quinoxalin-2-yl}benzenesulfonamide|Oprea1_087967|SCHEMBL1791384|N-[3-(3-hydroxyanilino)quinoxalin-2-yl]benzenesulfonamide|EX-A6622|ZINC3169448|AKOS024267255|HY-147314|CS-0565535|Z55701124|Benzenesulfonamide, N-[3-[(3-hydroxyphenyl)amino]-2-quinoxalinyl]- |
| Molecular Weight | 392.43 |
| Molecular Formula | C20H16N4O3S |
| Canonical SMILES | C1=CC=C(C=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=CC(=CC=C4)O |
| Purity | 98.35% |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Light yellow to yellow (Solid) |
| Storage | 4°C, protect from light * In solvent : -80°C, 6 months -20°C, 1 month (protect from light) |
| Complexity | 605 |
| Exact Mass | 392.09431156 |
| Target | HIV; Src |
| XLogP3-AA | 3.6 |
